These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38194265)

  • 21. The mechanism of Torsin ATPase activation.
    Brown RS; Zhao C; Chase AR; Wang J; Schlieker C
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4822-31. PubMed ID: 25352667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.
    Peterson JM; Seldin MM; Wei Z; Aja S; Wong GW
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G214-24. PubMed ID: 23744740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.
    Newberry EP; Xie Y; Kennedy SM; Graham MJ; Crooke RM; Jiang H; Chen A; Ory DS; Davidson NO
    Hepatology; 2017 Mar; 65(3):836-852. PubMed ID: 27862118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin-mediated differential regulation of microsomal triglyceride transfer protein in the intestine and liver affects plasma lipids.
    Iqbal J; Mascareno E; Chua S; Hussain MM
    J Biol Chem; 2020 Mar; 295(13):4101-4113. PubMed ID: 32047110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LULL1 retargets TorsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation.
    Vander Heyden AB; Naismith TV; Snapp EL; Hodzic D; Hanson PI
    Mol Biol Cell; 2009 Jun; 20(11):2661-72. PubMed ID: 19339278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
    Imai N; Suzuki M; Hayashi K; Ishigami M; Hirooka Y; Abe T; Shioi G; Goto H; Fujimoto T
    PLoS One; 2015; 10(5):e0127114. PubMed ID: 25970332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile acids induced hepatic lipid accumulation in mice by inhibiting mRNA expression of patatin-like phospholipase domain containing 3 and microsomal triglyceride transfer protein.
    Hashimoto N; Han KH; Wakagi M; Ishikawa-Takano Y; Ippoushi K; Fukushima M
    Nutr Res; 2021 Aug; 92():12-20. PubMed ID: 34174520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes.
    Deboyser D; Goethals F; Krack G; Roberfroid M
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):473-9. PubMed ID: 2609344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells.
    Taxiarchis A; Mahdessian H; Silveira A; Fisher RM; Van't Hooft FM
    J Lipid Res; 2019 Jun; 60(6):1069-1077. PubMed ID: 30918066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
    Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
    Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
    Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
    FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion.
    Amigo L; Zanlungo S; Miquel JF; Glick JM; Hyogo H; Cohen DE; Rigotti A; Nervi F
    J Lipid Res; 2003 Feb; 44(2):399-407. PubMed ID: 12576522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.
    Borén J; Adiels M; Björnson E; Matikainen N; Söderlund S; Rämö J; Ståhlman M; Ripatti P; Ripatti S; Palotie A; Mancina RM; Hakkarainen A; Romeo S; Packard CJ; Taskinen MR
    JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILDR2 has a negligible role in hepatic steatosis.
    Millings EJ; De Rosa MC; Fleet S; Watanabe K; Rausch R; Egli D; Li G; Leduc CA; Zhang Y; Fischer SG; Leibel RL
    PLoS One; 2018; 13(5):e0197548. PubMed ID: 29847571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
    Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
    Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.
    Mahdessian H; Taxiarchis A; Popov S; Silveira A; Franco-Cereceda A; Hamsten A; Eriksson P; van't Hooft F
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8913-8. PubMed ID: 24927523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fowl Adenovirus Serotype 4 Induces Hepatic Steatosis via Activation of Liver X Receptor-α.
    Yuan F; Hou L; Wei L; Quan R; Wang J; Liu H; Liu J
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
    Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
    J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.
    Mattijssen F; Georgiadi A; Andasarie T; Szalowska E; Zota A; Krones-Herzig A; Heier C; Ratman D; De Bosscher K; Qi L; Zechner R; Herzig S; Kersten S
    J Biol Chem; 2014 Jul; 289(28):19279-93. PubMed ID: 24876382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.